Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 3 Urinary Incontinence 2 Urologic Neoplasms 1 Testicular Neoplasms 1 Motor Activity 1 Lung Neoplasms 1 Castration-resistant Prostate Cancer 1

Interventions

Etoposide 30 Carboplatin 30 Cisplatin 23 Ifosfamide 22 Filgrastim 22 Paclitaxel 18 Peripheral Blood Stem Cell Transplantation 16 Bleomycin 13 Cyclophosphamide 11 Radiotherapy 8 Thiotepa 7 Magnetic Resonance Spectroscopy 6 Gemcitabine 6 pegfilgrastim 5 Therapeutics 5 Polymerase Chain Reaction 5 Melphalan 5 Granulocyte Colony-Stimulating Factor 5 Flow Cytometry 5 Busulfan 5 etoposide phosphate 4 Temozolomide 4 Psychiatric Rehabilitation 4 Oxaliplatin 4 Dexamethasone 4 sargramostim 3 Vinblastine 3 Taxes 3 Surveys and Questionnaires 3 Methylprednisolone 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Testicular Neoplasms × Control Groups × Genitourinary × Clear all

NCT02577172 2017-01-26

TAST

Oslo University Hospital

Phase NA Terminated

Motor Activity, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡